-+ 0.00%
-+ 0.00%
-+ 0.00%

CSL SEQIRUS EXPANDS U.S. AVAILABILITY OF INFLUENZA VACCINE FOLLOWING SUCCESSFUL COMPLETION OF THE 2026/27 MANUFACTURING CAMPAIGN

Reuters·09/29/2026 13:30:11

Please log in to view news